Abstract
BackgroundThe efficacy and safety profile of intravenous (IV) tocilizumab (TCZ) has been well established in patients (pts) with rheumatoid arthritis (RA). The aim of a subcutaneous (SC) TCZ dosing regimen...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have